Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia

PLoS Negl Trop Dis. 2020 May 18;14(5):e0008226. doi: 10.1371/journal.pntd.0008226. eCollection 2020 May.

Abstract

Background: After approximately 5 years of SAFE (surgery, antibiotics, facial cleanliness, environmental improvement) interventions for trachoma, hyperendemic (trachomatous inflammation-follicular (TF) ≥30%) districts remained in Amhara, Ethiopia. This study's aim was to characterize the epidemiology of Chlamydia trachomatis (Ct) infection and load among pre-school aged children living under the SAFE strategy.

Methods: Conjunctival swabs from a population-based sample of children aged 1-5 years collected between 2011 and 2015 were assayed to provide Ct infection data from 4 endemic zones (comprised of 58 districts). Ct load was determined using a calibration curve. Children were graded for TF and trachomatous inflammation-intense (TI).

Results: 7,441 children were swabbed in 4 zones. TF and TI prevalence were 39.9% (95% confidence Interval [CI]: 37.5%, 42.4%), and 9.2% (95% CI: 8.1%, 10.3%) respectively. Ct infection prevalence was 6.0% (95% CI: 5.0%, 7.2%). Infection was highest among children aged 2 to 4 years (6.6%-7.0%). Approximately 10% of infection occurred among children aged 1 year. Ct load decreased with age (P = 0.002), with the highest loads observed in children aged 1 year (P = 0.01) vs. aged 5 years. Participants with TF (P = 0.20) and TI (P<0.01) had loads greater than individuals without active trachoma.

Conclusions: In this hyperendemic setting, it appears that the youngest children may contribute in meaningful ways towards persistent active trachoma.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Child, Preschool
  • Chlamydia trachomatis / drug effects
  • Chlamydia trachomatis / physiology*
  • Conjunctiva / microbiology
  • Endemic Diseases / prevention & control
  • Ethiopia / epidemiology
  • Female
  • Humans
  • Infant
  • Male
  • Trachoma / drug therapy
  • Trachoma / epidemiology*
  • Trachoma / microbiology
  • Trachoma / prevention & control*

Substances

  • Anti-Bacterial Agents

Grants and funding

Funding for activities in 2013 was provided by USAID’s ENVISION project, managed by RTI International. The authors’ views expressed in this publication do not necessarily reflect the views of the US Agency for International Development (USAID) or the US government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.